Eloquest Healthcare News and Events

A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central catheters in place, compared to either suture-based or adhesive device-based securement methods. Read More.

A study at Dignity Health Mercy General Hospital showed that use of a special liquid adhesive to increase the durability of driveline (DL) dressings can reduce the risk of infection and improve quality of life for heart failure patients with left ventricular assist devices (LVADs). Read more.

The partnership adds the revolutionary SecurAcath device to Eloquest Healthcare’s existing clinically oriented product offering. Read more.

The partnership combines Eloquest’s existing clinically oriented product offering and commerical resources with AVI’s transformational device technology.

In 2019 and again in September of 2020, Eloquest Healthcare partnered with Adventist Health Global Missions to support their efforts of providing care and performing surgeries in remote communities abroad without access to these services.

Eloquest Healthcare is excited to announce new, 5-year MedSurg agreement with group purchasing organization Vizient Supply, LLC that will include Mastisol^® Liquid Adhesive, Detachol^® Adhesive Remover and ReliaTect^® Post-Op Dressing with CHG. Under the new agreement, Vizient members can take advantage of special pricing for these products.

Eloquest Healthcare, Inc. is honored to announce today announced that it is Great Place to Work-Certified™ for 2019-2020!

Eloquest Healthcare, Inc. is honored to announce that Fortune and Great Place to Work have recognized us as one of the 2018 Best Workplaces in Health Care & Biopharma!